67 results on '"Wells, Philip S"'
Search Results
2. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
3. A deep-learning approach to predict bleeding risk over time in patients on extended anticoagulation therapy
4. Machine learning analysis of bleeding status in venous thromboembolism patients
5. Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding—“This pill will keep you alive tonight”
6. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis
7. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy
8. Accuracy of physicians’ intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis
9. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism
10. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
11. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
12. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
13. Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study
14. Venous Thromboembolism Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis
15. Risk Stratification of Pulmonary Embolism
16. Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis
17. DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis
18. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study
19. Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE
20. Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension
21. DVT Management and Outcome Trends, 2001 to 2014
22. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
23. Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis
24. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
25. Factors that predict thrombosis in relatives of patients with venous thromboembolism
26. Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study
27. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation
28. Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
29. Pulmonary Embolism: A Clinician's Perspective
30. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
31. Blood Biomarkers for the Prediction of Venous Thromboembolism in Perioperative or Hospitalized Cancer Patients: A Systematic Review
32. Thrombophilia Gene Mutations for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
33. Performance of D-Dimers in Patients with Prior History of Venous Thromboembolism Based on Anticoagulation Status
34. A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3
35. The Management of Thrombophilia During Pregnancy: A Canadian Survey
36. Use of Low Molecular Weight Heparin in Acute Venous Thromboembolic Events in Pregnancy
37. Safety and Efficacy of Apixaban Thromboprophylaxis in Ambulatory Cancer Patients By Renal Function: A Subgroup Analysis of the Avert Trial
38. Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
39. Günther Tulip Filter: Preliminary Clinical Experience with Retrieval
40. Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial
41. Evidence-Based Diagnosis of Venous Thromboembolism: A Systematic Review
42. Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population
43. A BENEFIT-RISK ANALYSIS OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WHO CONTINUED VERSUS DISCONTINUED RIVAROXABAN THERAPY AFTER AN INITIAL SIX-MONTH THERAPY
44. Use of recombinant-hirudin in pulmonary thromboendarterectomy
45. Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status
46. RECURRENT VENOUS THROMBOEMBOLISM IN PULMONARY EMBOLISM PATIENTS WITH RIGHT VENTRICULAR DYSFUNCTION IN THE HOKUSAI-VTE STUDY
47. Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study
48. A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis
49. Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study
50. "Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.